Pinder, Emma M <br/><br/>
Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis.  [electronic resource] 

 -  Thorax  10 2018 
 - 918-925 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3296 
<br/><br/><label>Standard No.: </label>10.1136/thoraxjnl-2017-211323  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Critical Illness--therapy<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects<br/>HLA-DR Antigens--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Monocytes--metabolism<br/>Neutrophils--drug effects<br/>Phagocytosis--drug effects<br/>Treatment Outcome